GO:0046109 uridine biosynthetic process: Nucleotide Metabolism Pathway, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0046109 uridine biosynthetic process describes the chemical reactions and pathways that produce uridine, the uracil ribonucleoside that occurs almost entirely as phosphoric esters in ribonucleotides and RNA.
Uridine biosynthesis is a pyrimidine nucleotide pathway that supplies precursors for RNA synthesis, UDP-sugar metabolism, and tRNA modifications.
Uridine availability influences CD8+ T cell antitumor activity through N-glycosylation, linking this metabolic pathway to immune function.
Modified uridine analogues such as pseudouridine are used in mRNA therapeutics to enhance translation by diminishing PKR activation.
Uridine metabolism intersects with tRNA modification enzymes, redox homeostasis, and synapse formation, indicating roles beyond nucleotide supply.
Pharmacological modulation of uridine availability, including decitabine and cedazuridine combinations, demonstrates clinical relevance of pyrimidine metabolism.

Description

Uridine biosynthetic process (GO:0046109) is the set of chemical reactions and pathways that result in the formation of uridine, a ribonucleoside composed of uracil linked to ribose. Uridine is widely distributed in biology but occurs almost entirely as phosphoric esters within ribonucleotides and ribonucleic acids, making its biosynthesis a central node in pyrimidine metabolism. This pathway provides the activated precursors required for RNA synthesis, nucleotide sugar metabolism, and post-transcriptional RNA modifications. Researchers study uridine biosynthesis because it connects core metabolic flux to gene expression, immune cell function, and therapeutic RNA design. For example, uridine depletion impairs CD8+ T cell antitumor activity through N-glycosylation, showing that this pathway directly influences adaptive immunity. In addition, incorporation of pseudouridine, a uridine isomer, into mRNA enhances translation by diminishing PKR activation, highlighting how uridine-related chemistry can be engineered for therapeutic benefit. The pathway also intersects with tRNA modification enzymes that regulate redox homeostasis and synapse formation, suggesting broader roles in neurobiology. Pharmacological agents such as decitabine and cedazuridine modulate pyrimidine metabolism and are used in clinical settings, further underscoring the importance of understanding uridine biosynthesis.

uridine biosynthetic process At A Glance

GO ID GO:0046109
GO term uridine biosynthetic process
Ontology biological_process
Synonym uridine anabolism; uridine biosynthesis; uridine formation; uridine synthesis
Major function Formation of uridine, a ribonucleoside essential for ribonucleotide and RNA metabolism
Definition source QuickGO definition: The chemical reactions and pathways resulting in the formation of uridine, uracil riboside, a ribonucleoside very widely distributed but occurring almost entirely as phosphoric esters in ribonucleotides and ribonucleic acids.
Related pathways Pyrimidine metabolism, nucleotide sugar metabolism, RNA modification
Cellular context Cytoplasm and nucleus, with precursors derived from central metabolism

What Is GO:0046109?

In our own words, GO:0046109 uridine biosynthetic process refers to the biochemical reactions and pathways that lead to the production of uridine, the ribonucleoside of uracil. Uridine is a pyrimidine nucleoside that is widely distributed but exists almost entirely in phosphorylated forms within ribonucleotides and RNA. The term encompasses anabolic routes that generate uridine from simpler precursors, supporting downstream processes such as RNA synthesis and nucleotide-dependent glycosylation.

Why Is uridine biosynthetic process Important in Cell Biology?

Uridine biosynthetic process is important because it supplies uridine and its phosphorylated derivatives for fundamental cellular processes including RNA synthesis, protein glycosylation, and tRNA modification. Disruption of uridine availability can impair CD8+ T cell antitumor activity through N-glycosylation, linking this metabolic pathway to immune surveillance. Uridine-related chemistry is also central to mRNA therapeutics, where pseudouridine incorporation enhances translation by diminishing PKR activation. Moreover, tRNA modification enzymes that depend on uridine chemistry regulate redox homeostasis and synapse formation, indicating roles in neurobiology and cellular stress responses. Clinically, modulation of pyrimidine metabolism with agents such as decitabine and cedazuridine demonstrates the therapeutic relevance of this pathway.
Provides uridine precursors for RNA synthesis and ribonucleotide pools.
Supports protein N-glycosylation, which is required for CD8+ T cell antitumor activity.
Enables production of modified nucleosides such as pseudouridine for mRNA therapeutics.
Connects to tRNA modification pathways that regulate redox homeostasis and synapse formation.
Influences immune cell function and may affect immunotherapy outcomes.
Has clinical relevance through drugs that modulate pyrimidine metabolism, such as decitabine and cedazuridine.
Intersects with mTORC1 signaling and tRNA wobble modification to sustain protein synthesis.
May affect aminoglycoside potentiation through carbohydrate transporter activation.
Relevant to understanding metabolic vulnerabilities in cancer and immune cells.
Provides a target for metabolic engineering of RNA therapeutics.

What Happens During uridine biosynthetic process?

Precursor supply and pyrimidine ring formation
In simple terms: The cell first makes the building blocks that will become uridine.
Uridine biosynthesis begins with the assembly of the pyrimidine ring from simple precursors such as carbamoyl phosphate and aspartate, leading to orotate and then to uridine monophosphate (UMP). This de novo route provides the foundational pyrimidine nucleotide that can be converted to uridine. The pathway is tightly linked to central carbon and nitrogen metabolism, ensuring adequate precursor supply for nucleotide synthesis.
Conversion of UMP to uridine
In simple terms: The phosphorylated intermediate is trimmed to produce free uridine.
UMP is dephosphorylated by nucleotidases to yield uridine, which can then be salvaged or further metabolized. This step connects the biosynthetic pathway to salvage reactions and allows uridine to serve as a circulating nucleoside. Uridine availability can influence N-glycosylation and immune cell function, as shown by impaired CD8+ T cell antitumor activity upon uridine depletion.
Uridine phosphorylation and nucleotide pools
In simple terms: Uridine can be re-phosphorylated to feed into RNA and sugar metabolism.
Uridine is phosphorylated by uridine kinase to UMP, replenishing pyrimidine nucleotide pools. These pools support RNA synthesis and UDP-sugar metabolism, which are required for glycosylation reactions. The balance between uridine and its phosphorylated forms is critical for maintaining cellular functions, including protein synthesis and stress responses.
Uridine in RNA modification and therapeutic contexts
In simple terms: Uridine chemistry is used to modify RNA for better performance.
Uridine can be converted to modified nucleosides such as pseudouridine, which is incorporated into mRNA to enhance translation by diminishing PKR activation. This modification strategy is central to mRNA vaccine and therapeutic design. Additionally, tRNA modification enzymes that act on uridine derivatives regulate redox homeostasis and synapse formation, linking uridine metabolism to neurobiology.
Integration with mTORC1 and protein synthesis
In simple terms: Uridine metabolism communicates with growth signaling to support protein production.
mTORC1 cooperates with tRNA wobble modification to sustain the protein synthesis machinery, indicating that uridine-derived tRNA modifications are integrated with growth signaling. This coordination ensures that nucleotide availability matches the demands of protein synthesis. Dysregulation of this axis can affect cell growth and proliferation.

Key Genes Involved in GO:0046109 uridine biosynthetic process

The following genes and proteins are involved in uridine biosynthetic process and related pyrimidine metabolism, based on published literature.
GeneMajor RoleResearch Relevance
CADMultifunctional enzyme in de novo pyrimidine biosynthesisTarget for studying UMP synthesis and uridine production
UMPSConverts orotate to UMPKey enzyme in uridine biosynthetic process
UPP1Uridine phosphorylase, interconverts uridine and uracilRegulates uridine salvage and availability
UCK1Uridine-cytidine kinase 1, phosphorylates uridine to UMPControls uridine utilization for nucleotide pools
UCK2Uridine-cytidine kinase 2, phosphorylates uridineTissue-specific regulation of uridine metabolism
CMPK1UMP-CMP kinase, phosphorylates UMP to UDPLinks uridine to nucleotide sugar metabolism
NME1Nucleoside diphosphate kinase, produces UTPSupports RNA synthesis from uridine precursors
DKC1Pseudouridine synthase, modifies uridine in RNAConnects uridine to RNA modification and translation
PUS1Pseudouridine synthase, converts uridine to pseudouridineRelevant to mRNA therapeutics and tRNA modification
ELP1Elongator complex subunit, modifies tRNA uridineLinks uridine modification to redox homeostasis and synapse formation
ELP3Elongator acetyltransferase, modifies tRNA uridineStudied for tRNA acetylation mechanisms
ELP4Elongator complex subunitInvolved in tRNA wobble uridine modification
ELP5Elongator complex subunitComponent of tRNA modification machinery
ELP6Elongator complex subunitRequired for efficient tRNA modification
CTU1Thiolates tRNA wobble uridineRegulates translation fidelity and stress responses
CTU2Thiolates tRNA wobble uridineCooperates with mTORC1 to sustain protein synthesis
MTO1Mitochondrial tRNA uridine modificationLinks uridine modification to mitochondrial translation

How Is uridine biosynthetic process Regulated?

Uridine biosynthetic process is regulated at multiple levels, including transcriptional control of pyrimidine biosynthetic enzymes, feedback inhibition by downstream nucleotides, and integration with growth signaling pathways. mTORC1 cooperates with tRNA wobble modification to sustain the protein synthesis machinery, indicating that uridine-derived modifications are coupled to nutrient sensing. Uridine availability also influences N-glycosylation and CD8+ T cell antitumor activity, suggesting that immune signaling can be modulated by uridine levels. Additionally, tRNA modification enzymes that act on uridine derivatives regulate redox homeostasis and synapse formation, providing a link between uridine metabolism and cellular stress responses.

uridine biosynthetic process and Human Disease

GeneDisease / BiologyPotential Experimental Model
DKC1Dyskeratosis congenita, ribosomopathyKnockout or point-mutation cell models to study pseudouridine synthase function
ELP1Neurodevelopmental disorders, synaptic dysfunctionKnockout neurons to assess tRNA modification and redox homeostasis
ELP3Neurodegeneration, tRNA modification defectsKnock-in of patient variants to study Elongator function
CTU1Cancer, protein synthesis dysregulationKnockout cancer cell lines to test mTORC1 cooperation
UCK2Cancer metabolism, uridine dependencyOverexpression and knockout models to study uridine salvage
Cancer and immune evasion
Uridine depletion impairs CD8+ T cell antitumor activity through N-glycosylation, indicating that uridine biosynthetic process is important for immune-mediated tumor control. This suggests that tumors may exploit uridine metabolism to evade immune responses, and that targeting this pathway could enhance immunotherapy.
Neurodevelopmental and synaptic disorders
tRNA modification enzymes that depend on uridine chemistry regulate redox homeostasis and synapse formation, and their dysfunction has been linked to memory deficits. This connects uridine biosynthetic process to neurodevelopment and cognitive function.
Therapeutic RNA design and mRNA vaccines
Incorporation of pseudouridine, a uridine analogue, into mRNA enhances translation by diminishing PKR activation, which is critical for mRNA therapeutic efficacy. Understanding uridine biosynthesis supports the production of modified nucleosides for RNA-based medicines.
Pharmacological modulation of pyrimidine metabolism
Decitabine and cedazuridine are clinically used agents that modulate pyrimidine metabolism, demonstrating the therapeutic relevance of uridine-related pathways. These drugs highlight how altering nucleotide pools can affect disease outcomes.

From uridine biosynthetic process-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of UMPS affect uridine levels and RNA synthesis?UMPS knockout cell line
How does a point mutation in DKC1 affect pseudouridine modification?DKC1 point-mutation knock-in
Can uridine depletion enhance T cell antitumor activity?Conditional knockout in CD8+ T cells
Does overexpression of UCK2 increase nucleotide pools?UCK2 overexpression cell model
What is the role of ELP3 in tRNA modification?ELP3 knockout with tRNA sequencing
Does mTORC1 regulate CTU1-dependent wobble modification?CTU1 knockout with mTORC1 inhibition

How to Study the uridine biosynthetic process Process

MethodWhat It MeasuresTypical Application
LC-MS metabolomicsUridine and nucleotide levelsQuantify pathway flux after gene knockout
RNA-seqTranscriptome changesAssess gene expression upon uridine depletion
tRNA sequencingtRNA modification statusStudy pseudouridine and wobble modifications
Ribo-seqTranslation efficiencyMeasure protein synthesis changes
CRISPR knockout screensGene essentialityIdentify uridine pathway dependencies
Western blotProtein expressionValidate knockout or overexpression
Flow cytometryImmune cell functionAssess CD8+ T cell activity after uridine depletion
Glycosylation assaysN-glycosylation statusLink uridine to protein modification
Metabolomics and nucleotide quantification
Liquid chromatography-mass spectrometry (LC-MS) can quantify uridine and its phosphorylated derivatives to assess pathway activity. This method is essential for measuring changes in uridine biosynthetic flux upon genetic perturbation.
RNA sequencing and tRNA modification analysis
RNA-seq and specialized tRNA sequencing can detect changes in uridine-derived modifications such as pseudouridine and wobble uridine thiolation. These approaches link uridine metabolism to translation and RNA stability.
Ribosome profiling (Ribo-seq)
Ribo-seq measures translation efficiency and can reveal how uridine availability affects protein synthesis. It is particularly useful for studying the impact of tRNA modifications on codon-specific translation.
CRISPR screens and functional genomics
Genome-wide CRISPR knockout screens can identify genes required for uridine biosynthesis and salvage. Such screens help uncover metabolic vulnerabilities and synthetic lethal interactions.

How CRISPR Can Be Used to Study GO:0046109 uridine biosynthetic process

Knockout

CRISPR knockout of genes such as UMPS, UCK2, or DKC1 can reveal their essentiality in uridine biosynthetic process. Knockout cell models are used to measure uridine depletion and downstream effects on RNA synthesis and immune function.

Point Mutation

Point mutations in genes like DKC1 or ELP3 can model disease-associated variants and assess their impact on uridine modification and tRNA function. These models help dissect catalytic versus structural roles.

Knock-in

Knock-in of tagged or reporter alleles allows tracking of uridine biosynthetic enzymes in live cells. This approach can visualize subcellular localization and dynamics of the pathway.

Overexpression

Overexpression of UCK2 or UMPS can increase uridine flux and nucleotide pools, enabling studies of metabolic rewiring. Such models are useful for testing drug sensitivity and metabolic dependencies.

How EDITGENE Supports uridine biosynthetic process Research

Researchers studying uridine biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, disease progression, or therapeutic response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for uridine biosynthetic process research.

Frequently Asked Questions About uridine biosynthetic process

Uridine biosynthetic process (GO:0046109) is the set of chemical reactions and pathways that produce uridine, a ribonucleoside essential for RNA and nucleotide metabolism.
Key genes include CAD, UMPS, UCK1, UCK2, UPP1, and DKC1, among others involved in pyrimidine metabolism and RNA modification.
Uridine is required for RNA synthesis, protein glycosylation, and tRNA modifications, and its depletion impairs CD8+ T cell antitumor activity.
It is regulated by feedback inhibition, transcriptional control, and integration with mTORC1 signaling and tRNA modification pathways.
Dysregulation of uridine metabolism has been linked to cancer, neurodevelopmental disorders, and ribosomopathies.
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to study genes in this pathway.
Pseudouridine incorporation into mRNA enhances translation by diminishing PKR activation, improving therapeutic efficacy.
Uridine depletion impairs CD8+ T cell antitumor activity through N-glycosylation, highlighting its role in immune function.
LC-MS metabolomics, RNA-seq, tRNA sequencing, Ribo-seq, and CRISPR screens are commonly used.
Synonyms include uridine anabolism, uridine biosynthesis, uridine formation, and uridine synthesis.

Conclusion

Uridine biosynthetic process (GO:0046109) is a fundamental metabolic pathway that supplies uridine for RNA synthesis, glycosylation, and tRNA modification. Its importance extends to immune function, neurobiology, and therapeutic RNA design, as evidenced by studies on CD8+ T cell activity and pseudouridine-modified mRNA. Understanding the genes and regulatory mechanisms of this pathway offers opportunities for therapeutic intervention in cancer, metabolic disorders, and beyond. EDITGENE provides advanced CRISPR tools to accelerate research in this field.

References

  1. 1. Xiao J et al.. 2026. Uridine depletion impairs CD8⁺ T cell antitumor activity through N-glycosylation.. Cell Metab 38(3):616-632.e8 PMID: 41468885
  2. 2. Anderson BR et al.. 2010. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation.. Nucleic Acids Res 38(17):5884-92 PMID: 20457754
  3. 3. Madhwani KR et al.. 2024. tRNA modification enzyme-dependent redox homeostasis regulates synapse formation and memory.. Proc Natl Acad Sci U S A 121(46):e2317864121 PMID: 39495910
  4. 4. Lang M et al.. 2025. Uridine as a potentiator of aminoglycosides through activation of carbohydrate transporters.. Sci Adv 11(36):eadw7630 PMID: 40911672
  5. 5. Abbassi NE et al.. 2020. How Elongator Acetylates tRNA Bases.. Int J Mol Sci 21(21) PMID: 33152999
  6. 6. Hermann J et al.. 2025. mTORC1 cooperates with tRNA wobble modification to sustain the protein synthesis machinery.. Nat Commun 16(1):4201 PMID: 40328729
  7. 7. Unknown. 2020. Decitabine and Cedazuridine.. Am J Health Syst Pharm 77(22):1809-1811 PMID: 32945859
Contact Us
*
*
*
*
How did you hear about us: